Immunomodulating effect of 2,3,4,5-tetrahydro-1H-3-benzazepines (a new class of non-nucleoside inhibitors of reverse transcriptase)

International Journal of Antimicrobial Agents

Volumn 14, Issue 3, 2000, Pages 221-224

  Berek, Livia ^a   Petri, Ildiko B ^a   Varga, Eva ^a   Molnár, Joseph ^a   Kawase, Masami ^b   Saito, Setsuo ^b   Motohashi, Noboru ^c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b JOSAI UNIVERSITY   (Japan)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

2,3,4,5 Tetrahydro 1H 3 benzazepines; Blast transformation; Immunomodulating effect; NK reaction; Reverse transcriptase

Indexed keywords

3 BENZAZEPINE DERIVATIVE; IMMUNOMODULATING AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; BLAST TRANSFORMATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG STRUCTURE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; BENZAZEPINES; CELLS, CULTURED; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0034115334     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00125-4     Document Type: Article

References (15)

1. Nasca J., Hewlett I.K., Molnár J. Antiretroviral compounds focussed on reverse transcriptase. Non Antibiot. 1:1998;357-376.
2. Hewlett I.K., Lee S., Molnár J. et al. Inhibition of HIV infection of H9 cells by chlorpromazine derivatives. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 15:1997;16-20.
3. Artico M., Silvestri R., Pagnozzy E. et al. 5H-Pyrrolo[1,2,5]benzothiadiazepines (PBTDs): a novel class of non-nucleoside reverse transcriptase inhibitors. Bioorg. Med. Chem. 6:1996;837-850.
4. Kovacs T., Parnanyi L., Pelczer I. et al. Solid-state and solution conformation of 3′-amino-3′-deoxythymidine, precusor to a noncompetitive inhibitor of HIV-1 reverse transcriptase. J. Med. Chem. 34:1991;2595-2600.
5. Taylor P.B., Culp J.S., Debouck C. et al. Kinetic and mutational analysis of human immunodeficiency virus type 1, reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors. J. Biol. Chem. 9:1994;6325-6331.
6. Schffer W., Friebe W.G., Leinert H. et al. Non nucleoside inhibitors of HIV-1 reverse transcriptase molecular modeling and X-ray structure investigations. J. Med. Chem. 36:1993;726-732.
7. Proudfoot JR, Hargrave KD, Kapadia SR. Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase 4,2-substituted dipyridodiazepinones as potent inhibitors of both wild-type and cystein-181 HIV-1 reverse transcriptase enzymes, 1995;38:4830-38.
8. Molnár J., Szabo D., Miskolci Cs. et al. Effect of some new 3-benzazepines on plasmid DNA, mdr P-glycoprotein and reverse transcriptase of leukaemia. Non Antibiot. 1:1998;272-280.
9. Kawase M., Motohashi N., Niwa M. et al. Use of the triflamide group for Friedel-Crafts acylation of N-(β-phenethyl)amino acids to 3-benzazepine derivatives. Heterocycles. 45:1997;1121-1129.
10. Kawase M, Niwa M, Nozaki, et al. Synthesis of 2-trifluoromethyl-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives, Heterocycles 1998;48:555-60.
11. Molnár J., Mandi Y., Petri I. et al. Immuonomodulation activity of phenothiazines, benzo[a]phenothiazines. Anticancer Res. 13:1993;439-442.
12. Molnár J., Petri I., Berek I. et al. The effects of cannabinoids and cannabispiro compounds on Escherichia coli adhesion to tissue culture cells and on leukocytes functions in vitro. Acta Microbiol. Acad. Sci. Hung. 34:1987;233-240.
13. Petri I., Szekeres E., Berek I. et al. Effect of benzo[a]phenothiazines on natural killer cell activity of peripheral blood mononuclear cells. Anticancer Res. 13:1993;2273-2276.
14. Motohashi N, Kawase M, Saito S, et al. Plasmid elimination and immunomodulation by 3-benzazepines in vitro, Anticancer Res 1999.
15. Weinstock J., Hieble J.P., Wilson J.W. The chemistry and pharmacology of 3-benzazepines. Drugs Future. 10:1985;645-696.